Search results for "severity"

showing 10 items of 1287 documents

Severe eosinophilic asthma: a roadmap to consensus

2017

Asthma is widely accepted as a complex heterogeneous condition with diverse pathophysiological mechanisms, clinical presentations, comorbidities, physiological characteristics, pathology and outcomes that is typically best managed by a multidisciplinary team [1–4]. Severe asthma is recognised as a major unmet need with a high personal and social impact, as well as a high burden on healthcare resources [4]. As a consequence of advances in the development of precision medicines for patients with severe asthma, the need to identify asthma subtypes by phenotype based on clinical, functional or inflammatory parameters is becoming a mandatory part of management [4–6]. Severe eosinophilic asthma (…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyConsensusEosinophilic asthmamacromolecular substancesSeverity of Illness IndexBiological Factors03 medical and health sciences0302 clinical medicineimmune system diseasesEosinophilicmedicineHumans030212 general & internal medicinePulmonary EosinophiliaIntensive care medicineSocieties MedicalTask forcebusiness.industryDisease ManagementAsthmarespiratory tract diseasesEurope030228 respiratory systemImmunologybusinessEuropean Respiratory Journal
researchProduct

Defining moderate asthma exacerbations in clinical trials based on ATS/ERS joint statement

2015

Background Exacerbations are a key outcome in clinical research, providing patient-relevant information about symptomatic control, health state and disease progression. Generally considered as an episode of (sub)acute deterioration of respiratory symptoms, a precise, clinically useful definition is needed for use in clinical trials. Aim and methods Focussing on moderate exacerbations, this opinion piece reviews landmark trials and current guidelines to provide a practical definition of a moderate exacerbation. Specifically, we adapt the ATS/ERS consensus statement of terminology Reddel et al. (2009) [1] which provides a conceptual (or 'theoretical') definition for moderate exacerbations, to…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyExacerbationStatement (logic)Moderate asthmaSeverity of Illness IndexAdrenal Cortex HormonesAsthma controlAdministration InhalationmedicineHumansModerate exacerbationsAnti-Asthmatic AgentsBaseline (configuration management)Randomized Controlled Trials as TopicAsthmaOperational definitionbusiness.industrymedicine.diseaseAsthmaClinical trialClinical trialClinical researchPractice Guidelines as TopicDisease ProgressionPhysical therapyEmergency Service HospitalbusinessRespiratory Medicine
researchProduct

Mitral valve annuloplasty and papillary muscle relocation oriented by 3-dimensional transesophageal echocardiography for severe functional mitral reg…

2012

Objective The study of the mitral valve apparatus and its modifications during functional mitral regurgitation (FMR) is better revealed by 3-dimensional (3D) transesophageal echocardiography (TOE). To plan mitral valve repair by annuloplasty and papillary muscle (PPM) relocation, we proposed a valve repair procedure oriented by the new main features obtained by real-time 3D TOE reconstruction of the mitral valve apparatus. Methods Since January 2008, 25 patients with severe FMR before mitral valve repair were examined. Mean coaptation depth and mean tenting area were 1.3 ± 0.2 cm and 3.2 ± 0.5 cm 2 , respectively. Intraoperative 2D and 3D TOE were performed, followed by a 3D offline reconst…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyMitral Valve Annuloplastymedicine.medical_treatmentEchocardiography Three-DimensionalSeverity of Illness Index3 dimensional transesophageal echocardiographyBlood Vessel Prosthesis ImplantationPredictive Value of TestsMitral valve annuloplastyInternal medicineMitral valveImage Interpretation Computer-AssistedMedicineHumansFunctional mitral regurgitationPapillary muscleAgedMitral valve repairMitral regurgitationbusiness.industryRing annuloplastyMitral Valve InsufficiencySettore MED/23 - Chirurgia CardiacaMiddle AgedPapillary Musclesmedicine.anatomical_structureTreatment OutcomeMitral valve annuloplastyItalycardiovascular systemCardiologyMitral ValveSurgeryCardiology and Cardiovascular MedicinebusinessEchocardiography TransesophagealThe Journal of thoracic and cardiovascular surgery
researchProduct

Eligibility for treatment with omalizumab in Italy and Germany.

2013

Summary Omalizumab is an add-on therapy for patients with uncontrolled severe allergic asthma. In Europe, patients must fulfil a number of additional criteria to become eligible for omalizumab therapy, creating a challenge for epidemiology studies to quantify the potential patient pool. Thus, and in the absence of robust data, the number of omalizumab-eligible patients has remained unclear. To assess eligible patient numbers, a chart-audit design approach was employed to measure epidemiology variables based on patient-level data. 770 patient charts were reviewed in designated towns in Germany and Italy, in collaboration with >200 primary care physicians (PCPs) and respiratory specialists (R…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyPediatricsReferralEpidemiologySevere asthmaAllergic asthmaEligibility DeterminationOmalizumabPrimary careOmalizumabAntibodies Monoclonal HumanizedSeverity of Illness IndexAntibodiesSampling StudiesDose-Response RelationshipProduct LabelGermanyEpidemiologyMonoclonalmedicinePrevalenceHumansNational levelAnti-Asthmatic AgentsHumanizedAnti-immunoglobulin EEligibilityDose-Response Relationship Drugbusiness.industryPatient SelectionAllergic asthmaImmunoglobulin EAsthmaAntibodies Anti-IdiotypicAnti-IdiotypicTreatment OutcomeItalyQuality of LifeBiological MarkersDrugbusinessBiomarkersmedicine.drugAllergic asthma; Anti-immunoglobulin E; Eligibility; Epidemiology; Anti-Asthmatic Agents; Antibodies Anti-Idiotypic; Antibodies Monoclonal Humanized; Asthma; Biological Markers; Dose-Response Relationship Drug; Eligibility Determination; Germany; Humans; Immunoglobulin E; Italy; Patient Selection; Prevalence; Quality of Life; Sampling Studies; Severity of Illness Index; Treatment OutcomeRespiratory medicine
researchProduct

Advances in asthma pathophysiology: stepping forward from the Maurizio Vignola experience

2015

Maurizio Vignola was a superb and innovative researcher, who wrote seminal papers on the biology of airway epithelium in asthma. Inflammation and remodelling were the main topics of his research, mostly conducted in biopsy specimens from patients with asthma of variable severity, encompassing the entire spectrum of the disease from mild to severe asthma. His observations contributed to define the biology of asthma as we know it today, and opened the way to the personalised treatment of asthma. His group has successfully continued to investigate the biology and clinical aspects of bronchial asthma, with major interest in the clinical use of biomarkers to monitor disease activity, and in the …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyVariable severityAsthma phenotypesSevere asthmaDrug ResistanceMEDLINEDiseaseSettore MED/10 - Malattie Dell'Apparato RespiratorioAdrenal Cortex HormoneDisease activityGlucocorticoidAdrenal Cortex Hormonesimmune system diseasesmedicineHumansIntensive care medicineGlucocorticoidsAsthmalcsh:RC705-779Inflammationbusiness.industrylcsh:Diseases of the respiratory systemBiomarkermedicine.diseaseAsthmarespiratory tract diseasesPhysical therapyAirway RemodelingTreatment strategybusinessBiomarkersHumanEuropean Respiratory Review
researchProduct

Diabetes Mellitus Prevalence and Control in Sleep-Disordered Breathing

2014

BACKGROUND OSA is associated with an increased risk of cardiovascular morbidity. A driver of this is metabolic dysfunction and in particular type 2 diabetes mellitus (T2DM). Prior studies identifying a link between OSA and T2DM have excluded subjects with undiagnosed T2DM, and there is a lack of population-level data on the interaction between OSA and glycemic control among patients with diabetes. We assessed the relationship between OSA severity and T2DM prevalence and control in a large multinational population. METHODS We performed a cross-sectional analysis of 6,616 participants in the European Sleep Apnea Cohort (ESADA) study, using multivariate regression analysis to assess T2DM preva…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyendocrine system diseasesmedicine.diagnostic_testCross-sectional studybusiness.industrynutritional and metabolic diseasesSleep apneaType 2 Diabetes MellitusPolysomnographyCritical Care and Intensive Care Medicinemedicine.diseaseMedication prescriptionrespiratory tract diseasesApnea–hypopnea indexInternal medicineCohortSeverity of illnessPhysical therapymedicineCardiology and Cardiovascular MedicinebusinessChest
researchProduct

Frailty Assessment in a Stable COPD Cohort: Is There a COPD-Frail Phenotype?

2021

The frailty syndrome increases the morbidity/mortality in older adults, and several studies have shown a higher prevalence of this syndrome in patients with Chronic Obstructive Pulmonary Disease (COPD). The aim of this study was to identify the characteristics of frail patients with COPD to define a new phenotype called "COPD-frail." We conducted a cross-sectional study in a cohort of patients with stable COPD, classified as either frail, pre-frail, or non-frail. Sociodemographic, clinical, and biochemical variables were compared between the three groups of patients. The study included 127 patients, of which 31 were frail, 64 were pre-frail, and 32 non-frail. All subjects had FEV1/FVC below…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyphenotypeFrail ElderlyFrailty syndromefrailtyHospital Anxiety and Depression ScaleSeverity of Illness IndexFEV1/FVC ratioPulmonary Disease Chronic ObstructiveInternal medicineMedicineCOPDHumansAgedCOPD-frailCOPDFrailtybusiness.industrymedicine.diseaseObstructive lung diseaserespiratory tract diseasesCross-Sectional StudiesDyspneaPhenotypeCohortAnxietymedicine.symptombusinessBody mass indexhuman activitiesCOPD
researchProduct

Oxidative and nitrosative stress in the diaphragm of patients with COPD.

2007

COPD is associated with an increased load on the diaphragm. Since chronic muscle loading results in changes in antioxidant capacity and formation of reactive oxygen and reactive nitrogen species, we hypothesized that COPD has a similar effect on the diaphragm, which is related to the severity of COPD. Catalase activity was determined spectrophotometrically. Levels of 4-hydroxy-2-nonenal (HNE)-protein adducts and 3-nitrotyrosine (NT) formation were measured using western blotting. Levels of malondialdehyde (MDA) were assessed by high-performance liquid chromatography. We found that catalase activity was approximately 89% higher in the diaphragm of severe COPD patients (FEV1 37+/-5% predicted…

Pulmonary and Respiratory Medicinemedicine.medical_specialtyrespiratory musclesNitrosationDiaphragmOxidative phosphorylationmedicine.disease_causeSeverity of Illness IndexNOLipid peroxidationPulmonary Disease Chronic Obstructivechemistry.chemical_compoundInternal medicineHumansCOPDMedicineReactive nitrogen speciesOriginal ResearchCOPDoxidantsbiologybusiness.industryHealth PolicyPublic Health Environmental and Occupational HealthGeneral MedicineMiddle Agedmedicine.diseaseMalondialdehydeDiaphragm (structural system)Surgeryrespiratory tract diseasesOxidative StressantioxidantsEndocrinologychemistryCatalasebiology.proteinbusinessOxidative stressInternational journal of chronic obstructive pulmonary disease
researchProduct

Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 …

2021

Background The use of Renin-Angiotensin system inhibitors (RASi) in patients with coronavirus disease 2019 (COVID-19) has been questioned because both share a target receptor site. Methods HOPE-COVID-19 (NCT04334291) is an international investigator-initiated registry. Patients are eligible when discharged after an in-hospital stay with COVID-19, dead or alive. Here, we analyze the impact of previous and continued in-hospital treatment with RASi in all-cause mortality and the development of in-stay complications. Results We included 6503 patients, over 18 years, from Spain and Italy with data on their RASi status. Of those, 36.8% were receiving any RASi before admission. RASi patients were …

QA75Malemedicine.medical_specialtyHeart diseaseInfecciones por coronavirusmedicine.medical_treatmentInhibidores enzimáticosPopulationClinical InvestigationsEnfermedad transmisibleAngiotensin-Converting Enzyme InhibitorsSistema renina-angiotensinaComorbidity030204 cardiovascular system & hematologySeverity of Illness Index03 medical and health sciences0302 clinical medicineRisk FactorsOutcome Assessment Health CareSeverity of illnessmedicineHumansRegistries030212 general & internal medicineMedical prescriptioneducationHeart FailureMechanical ventilationeducation.field_of_studySARS-CoV-2business.industryCOVID-19Middle AgedPrognosismedicine.diseaseR1Respiration ArtificialComorbidityHospitalizationItalySpainHeart failureEmergency medicineFemaleObservational studyCardiology and Cardiovascular MedicinebusinessAmerican Heart Journal
researchProduct

Severe asthma features in children: A case–control online survey

2016

Background Very few studies have explored the distinguishing features of severe asthma in childhood in Europe, and only one study was conducted in Southern Europe. The aim of this study was to provide a detailed characterization of children with severe asthma treated in specialized pediatric asthma centers across Italy. Methods We conducted a web-based data collection of family, environmental, clinical and laboratory characteristics of 41 patients aged 6–17 years with severe asthma, defined according to the recent guidelines of the European Respiratory Society and the American Thoracic Society, and 78 age-matched peers with non-severe persistent asthma. The patients have been enrolled from …

Quality of lifeMalePediatricsmedicine.medical_specialtyAllergyAdolescentmacromolecular substancesSeverity of Illness IndexPediatricsAtopy03 medical and health sciences0302 clinical medicineQuality of lifeSurveys and QuestionnairesSeverity of illnessmedicineHumansAsthma; Atopy; Children; Lung function; Quality of life; Pediatrics Perinatology and Child Health030212 general & internal medicineChildChildrenAsthmaRespiratory Function Testbusiness.industryAtopyResearchCase-control studyAsthma; Atopy; Children; Lung function; Quality of life; Adolescent; Asthma; Case-Control Studies; Child; Female; Humans; Italy; Male; Quality of Life; Respiratory Function Tests; Severity of Illness Index; Surveys and Questionnaires; Pediatrics Perinatology and Child HealthOdds ratioAdolescent; Asthma; Case-Control Studies; Child; Female; Humans; Italy; Male; Quality of Life; Respiratory Function Tests; Severity of Illness Index; Surveys and QuestionnairesPerinatology and Child Healthmedicine.diseaseAsthmaLung functionrespiratory tract diseasesRespiratory Function Tests030228 respiratory systemItalyCase-Control StudiesExhaled nitric oxidePediatrics Perinatology and Child HealthFemalebusinessCase-Control StudieHuman
researchProduct